FarFaR - Farmaceutski fakultet, repozitorijum
FarFaR je zajednički digitalni repozitorijum svih odeljenja u okviru Univerziteta u Beogradu - Farmaceutskog fakulteta. FarFaR omogućava otvoreni pristup publikacijama, kao i ostalim rezultatima nastalim u okviru projekata koje se izvode na Farmaceutskom fakultetu.
Softverska platforma repozitorijuma prilagođena je savremenim standardima koji se primenjuju u diseminaciji naučnih publikacija i kompatibilna je sa međunarodnom infrastrukturom u ovoj oblasti.
Eksterna aplikacija Autori, projekti, publikacije (APP) omogućava pregled i pretraživanje podataka o autorima i projektima, prenos metapodataka u druge sisteme, integraciju sa servisom Altmetric i prikaz podataka o citiranosti u indeksnim bazama podataka Dimensions , Scopus i Web of Science.
Institucije/grupe
Izaberite instituciju/grupu
Najnovije
-
The influence of Klotho protein and prooxidant–antioxidant balance combination on the mortality of HD patients
(Springer Science and Business Media B.V., 2024) -
Factors associated with hematological adverse reactions of drugs authorized via the centralized procedure
(Nature Portfolio, 2024) -
Drug-Related Problems Prior to Hospitalization on Internal Medicine Wards
(Polish Pharmaceutical Society, 2024) -
Comparative evaluation of tableting properties of microcrystalline cellulose obtained from wheat and corn crop residues
(International Association for Pharmaceutical Technology (APV), Mainz, Germany, International Society of Drug Delivery Sciences and Technology (APGI), Lille, France, Italian Society of Technology and Legislation (S.I.T.E.L.F), Milan, Italy, 2024) -
Evaluation of novel compounds as anti-bacterial or anti-virulence agents
(Frontiers Media SA, 2024) -
Obesity and dyslipidemia in early life: Impact on cardiometabolic risk
(W.B. Saunders, 2024) -
An overview of current vacccines for the prophylaxis of bacterical infections Pres / Pregled aktuelnih vakcina za profilaksu bakterijskih infekcija
(Udruženja za preventivnu pedijatriju Srbije, 2024) -
Overcoming the low solubility of novel pyrazoloquinolinone ligand (CW-02-79) by combination of drug-phospholipid complex and nanoemulsion technology: design and physicochemical evaluation
(International Society of Drug Delivery Sciences and Technology (APGI), International Association for Pharmaceutical Technology (APV), Italian Society of Technology and Legislation (S.T.E.L.F), 2024)